These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36316614)

  • 21. [A comparative study on the efficacy and safety of intravenous esmolol, amiodarone and diltiazem for controlling rapid ventricular rate of patients with atrial fibrillation during anesthesia period].
    Shen SL; Zhao YC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):989-92. PubMed ID: 21215227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation.
    Shin H; Cho MC; Kim RB; Kim CH; Choi NC; Kim SK; Koh EH
    J Thromb Thrombolysis; 2018 Feb; 45(2):250-256. PubMed ID: 29198080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function.
    Pham P; Schmidt S; Lesko L; Lip GYH; Brown JD
    JAMA Netw Open; 2020 Apr; 3(4):e203593. PubMed ID: 32329770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of global laboratory methods and establishing on-therapy ranges for monitoring apixaban and rivaroxaban: Experience at a single institution.
    Park SH; Seo YH; Park PW; Kim KH; Seo JY; Lee HT; Kwoun WJ; Ahn JY
    J Clin Lab Anal; 2019 Jun; 33(5):e22869. PubMed ID: 30860622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban.
    Frost C; Song Y; Barrett YC; Wang J; Pursley J; Boyd RA; LaCreta F
    Clin Pharmacol; 2014; 6():179-87. PubMed ID: 25419161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction of diltiazem with lovastatin and pravastatin.
    Azie NE; Brater DC; Becker PA; Jones DR; Hall SD
    Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data.
    Hirai T; Kasai H; Naganuma M; Hagiwara N; Shiga T
    BMC Pharmacol Toxicol; 2022 Feb; 23(1):14. PubMed ID: 35144695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diltiazem versus amiodarone to prevent atrial fibrillation in coronary surgery.
    Mikroulis D; Didilis V; Konstantinou F; Tsakiridis K; Vretzakis G; Bougioukas G
    Asian Cardiovasc Thorac Ann; 2005 Mar; 13(1):47-52. PubMed ID: 15793051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjects.
    Dingemanse J; Nicolas L
    Clin Drug Investig; 2013 Mar; 33(3):207-13. PubMed ID: 23381958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma apixaban levels in Chinese patients with chronic kidney disease-Relationship with renal function and bleeding complications.
    Sin CF; Wong KP; Wong TF; Siu CW; Yap DYH
    Front Pharmacol; 2022; 13():928401. PubMed ID: 36569289
    [No Abstract]   [Full Text] [Related]  

  • 32. Postoperative outcome of patients undergoing lung resection presenting with new-onset atrial fibrillation managed by amiodarone or diltiazem.
    Bobbio A; Caporale D; Internullo E; Ampollini L; Bettati S; Rossini E; Carbognani P; Rusca M
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):70-4. PubMed ID: 17113780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients.
    Mavrakanas TA; Samer CF; Nessim SJ; Frisch G; Lipman ML
    J Am Soc Nephrol; 2017 Jul; 28(7):2241-2248. PubMed ID: 28302754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial.
    Zeitouni M; Giczewska A; Lopes RD; Wojdyla DM; Christersson C; Siegbahn A; De Caterina R; Steg PG; Granger CB; Wallentin L; Alexander JH;
    J Am Coll Cardiol; 2020 Mar; 75(10):1145-1155. PubMed ID: 32164888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
    Graney WF
    Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma apixaban concentrations and thrombin generation assay parameters in response to dose reduction for atrial fibrillation.
    Yeo M; Lee SR; Choi EK; Choi J; Lee KY; Ahn HJ; Kwon S; Park HS; Kim HK; Oh S; Lip GYH
    Br J Clin Pharmacol; 2024 Aug; ():. PubMed ID: 39147597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
    Piccini JP; Caso V; Connolly SJ; Fox KAA; Oldgren J; Jones WS; Gorog DA; Durdil V; Viethen T; Neumann C; Mundl H; Patel MR;
    Lancet; 2022 Apr; 399(10333):1383-1390. PubMed ID: 35385695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of confidence intervals to describe the precision of trough/peak ratios for diltiazem CD in the treatment of hypertension.
    Meeves SG; Park GD
    J Clin Pharmacol; 1994 Mar; 34(3):231-5. PubMed ID: 8021331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation.
    Ueshima S; Hira D; Fujii R; Kimura Y; Tomitsuka C; Yamane T; Tabuchi Y; Ozawa T; Itoh H; Horie M; Terada T; Katsura T
    Pharmacogenet Genomics; 2017 Sep; 27(9):329-336. PubMed ID: 28678049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.